CaliPharms, Inc. (KGET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 22, 2025
CaliPharms Revenue
CaliPharms had revenue of $59.96K in the quarter ending September 30, 2014. This brings the company's revenue in the last twelve months to $112.47K.
Revenue (ttm)
112.47K
Revenue Growth
n/a
P/S Ratio
0.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.88K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Jun 30, 2012 | - | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |